InVivo poaches Stryker exec for VP of business development
InVivo Therapeutics (OTC:NVIV) snagged former Stryker (NYSE:SYK) spinal executive Robert Housler Jr., naming him the new vice president of business development.
Housler spent the last 5 years creating Stryker’s business development strategy, growing domestic sales to $440 million. At InVivo he will focus on the company’s efforts to get a foothold in the chronic peripheral nerve pain market.
Read more
Echo Therapeutics names Dave Walton VP of marketing & commercial development
Echo Therapeutics (NSDQ:ECTE) appointed Dave Walton, a former Johnson & Johnson (NYSE:JNJ) diabetes executive, its new VP of marketing & commercial development to lead strategic market planning for the company’s Symphony transdermal continuous glucose monitoring systems.
Read more
Avery Biomedical appoints Dr. Don Burdett Headley as clinical consultant
Avery Biomedical Devices named board-certified otolaryngologist Dr. Don Burdett Headley its new clinical consultant, as which he will provide lectures on diaphragm pacing and will be available for clinical discussions regarding the company’s breathing pacemaker.
Read more